YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Vytorin
Drug Makers Decry FDA Safety Push
Jul 1, 2008 | Parker Waichman Alonso LLP
Drug makers are complaining that the Food & Drug Administration (FDA) is too focused on, of all things, safety. The pharmaceutical industry...
Senator McCain Quit Vytorin After ENHANCE
May 28, 2008 | Parker Waichman Alonso LLP
Many former Vytorin patients switched off the expensive drug after a study -called ENHANCE - released earlier this year showed it was no more...
Vytorin Study Probed by US Justice Department
May 9, 2008 | Parker Waichman Alonso LLP
The US Justice Department wants to know more about a crucial Vytorin study, the results of which were concealed for more than a year. ...
Lawmakers Lean on FDA to Police Drug Advertising
May 8, 2008 | Parker Waichman Alonso LLP
Last month, Congress asked the Food and Drug Administration (FDA) to speed its efforts in forcing drug companies to include safety-reporting...
Vytorin, Procrit, Lipitor TV Ads Subject of Congress Probe
May 6, 2008 | Parker Waichman Alonso LLP
A U.S. congressional panel is now examining television ads for cholesterol drugs Lipitor and Vytorin and for the anemia drug Procrit at a Thursday...
FDA Planning Hiring Blitz
May 1, 2008 | Parker Waichman Alonso LLP
The beleaguered Food & Drug Administration (FDA) is planning on filling over 1,300 positions by the end of September, triple the amount hired by...
FDA Considering Biomarkers As a Way to Improve Drug Safety
Apr 17, 2008 | Parker Waichman Alonso LLP
A new way of testing experimental drugs is being considered by the Food & Drug Administration (FDA). If adopted, the FDA could end up...
Vytorin Investigation Focuses on Minutes of November Meeting
Apr 14, 2008 | Parker Waichman Alonso LLP
Lawmakers probing Vytorin have discovered that Merck and Schering-Plough had minutes of a key meeting about the drug written weeks after the event...
FDA Official Says Agency Won't Take Sides on Vytorin - Then Defends Vytorin
Apr 11, 2008 | Parker Waichman Alonso LLP
Criticism of Vytorin is unfair, a Food & Drug Administration (FDA) official said this week. However, CDER director Janet Woodcock said the...
New Vytorin Orders Fall
Apr 10, 2008 | Parker Waichman Alonso LLP
New prescriptions for Vytorin were down last week, following last month's recommendations from some top cardiologists that Vytorin be used only as a...
Vytorin
